Synthesis and characterization of biomimetic citrate-based biodegradable composites

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 8, 2014, Pages 2521-2532

  Tran, Richard T ^a   Wang, Liang ^b,c   Zhang, Chang ^d   Huang, Minjun ^b,c   Tang, Wanjin ^e   Zhang, Chi ^e   Zhang, Zhongmin ^b,c   Jin, Dadi ^b,c   Banik, Brittany ^a   Brown, Justin L ^a   Xie, Zhiwei ^a   Bai, Xiaochun ^b,c   Yang, Jian ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d University of Texas at Arlington   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

biodegradable composites; bone tissue engineering; citric acid; osterix

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOMIMETIC MATERIALS; BIOMIMETIC PROCESSES; BONE; CELL CULTURE; CITRIC ACID; COMPRESSIVE STRENGTH; GENE EXPRESSION; HYDROXYAPATITE; MOLECULES; OSTEOBLASTS; PHOSPHATASES; TISSUE ENGINEERING;

BIODEGRADABLE COMPOSITES; BIOMIMETIC COMPOSITES; BONE TISSUE ENGINEERING; LOAD BEARING FUNCTIONS; ORTHOPEDIC APPLICATIONS; ORTHOPEDIC BIOMATERIALS; OSTERIX; SYNTHESIS AND CHARACTERIZATIONS;

CROSSLINKING;

ALKALINE PHOSPHATASE; BIOMIMETIC MATERIAL; CITRATE BASED POLYMER BLEND; CITRIC ACID; ELASTOMER; HYDROXYAPATITE; POLY(OCTANEDIOL CITRATE); POLYESTER; POLYMER; TRANSCRIPTION FACTOR OSTERIX; UNCLASSIFIED DRUG; URETHAN DERIVATIVE; BIOMATERIAL; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; HERMES ANTIGEN; HYALURONAN-MEDIATED MOTILITY RECEPTOR; LEUKOCYTE ANTIGEN; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BONE CONDUCTION; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CHEMICAL BINDING; COMPOSITE MATERIAL; COMPRESSIVE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; CROSS LINKING; CULTURE MEDIUM; DEGRADATION; ENCAPSULATION; FEMUR CONDYLE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MESENCHYME CELL; NONHUMAN; OSTEOBLAST; PHENOTYPE; POLYMERIZATION; SUPPLEMENTATION; SYNTHESIS; ANIMAL; BONE REGENERATION; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; MATERIALS TESTING; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MOUSE; PROCEDURES; RABBIT;

ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOCOMPATIBLE MATERIALS; BIOMIMETIC MATERIALS; CELL DIFFERENTIATION; CELL LINE; CITRIC ACID; DURAPATITE; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MATERIALS TESTING; MICE; OSSEOINTEGRATION; OSTEOBLASTS; POLYMERS; RABBITS; X-RAY MICROTOMOGRAPHY;

EID: 84903278905     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34928     Document Type: Article

References (50)

1. Munch E, Launey ME, Alsem DH, Saiz E, Tomsia AP, Ritchie RO,. Tough, bio-inspired hybrid materials. Science 2008; 322: 1516-1520.
2. Place ES, Evans ND, Stevens MM,. Complexity in biomaterials for tissue engineering. Nat Mater 2009; 8: 457-470.
3. Tsigkou O, Pomerantseva I, Spencer JA, Redondo PA, Hart AR, O'Doherty E, Lin Y, Friedrich CC, Daheron L, Lin CP, et al. Engineered vascularized bone grafts. Proc Natl Acad Sci USA 2010; 107: 3311-3316.
4. Bowles RD, Gebhard HH, Hartl R, Bonassar LJ,. Tissue-engineered intervertebral discs produce new matrix, maintain disc height, and restore biomechanical function to the rodent spine. Proc Natl Acad Sci USA 2011; 108: 13106-13111.
5. Grayson WL, Frohlich M, Yeager K, Bhumiratana S, Chan ME, Cannizzaro C, Wan LQ, Liu XS, Guo XE, Vunjak-Novakovic G. Engineering anatomically shaped human bone grafts. Proc Natl Acad Sci USA 2009; 107: 3299-3304.
6. Liu H, Webster TJ,. Mechanical properties of dispersed ceramic nanoparticles in polymer composites for orthopedic applications. Int J Nanomed 2010; 5: 299-313.
7. Rizzi SC, Heath DJ, Coombes AG, Bock N, Textor M, Downes S,. Biodegradable polymer/hydroxyapatite composites: Surface analysis and initial attachment of human osteoblasts. J Biomed Mater Res 2001; 55: 475-486.
8. Saito M, Maruoka A, Mori T, Sugano N, Hino K,. Experimental studies on a new bioactive bone cement: Hydroxyapatite composite resin. Biomaterials 1994; 15: 156-160.
9. Wagoner Johnson AJ, Herschler BA,. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater 2011; 7: 16-30.
10. Saito N, Okada T, Horiuchi H, Murakami N, Takahashi J, Nawata M, Ota H, Nozaki K, Takaoka K,. A biodegradable polymer as a cytokine delivery system for inducing bone formation. Nat Biotechnol 2001; 19: 332-335.
11. Gentleman E, Swain RJ, Evans ND, Boonrungsiman S, Jell G, Ball MD, Shean TA, Oyen ML, Porter A, Stevens MM,. Comparative materials differences revealed in engineered bone as a function of cell-specific differentiation. Nat Mater 2009; 8: 763-770.
12. Bhumiratana S, Grayson WL, Castaneda A, Rockwood DN, Gil ES, Kaplan DL, Vunjak-Novakovic G,. Nucleation and growth of mineralized bone matrix on silk-hydroxyapatite composite scaffolds. Biomaterials 2011; 32: 2812-2820.
13. Brauer DS, Russel C, Vogt S, Weisser J, Schnabelrauch M,. Fabrication and in vitro characterization of porous biodegradable composites based on phosphate glasses and oligolactide-containing polymer networks. J Biomed Mater Res A 2007; 80: 410-420.
14. Chesnutt BM, Viano AM, Yuan Y, Yang Y, Guda T, Appleford MR, Ong JL, Haggard WO, Bumgardner JD,. Design and characterization of a novel chitosan/nanocrystalline calcium phosphate composite scaffold for bone regeneration. J Biomed Mater Res A 2009; 88: 491-502.
15. Kane RJ, Converse GL, Roeder RK,. Effects of the reinforcement morphology on the fatigue properties of hydroxyapatite reinforced polymers. J Mech Behav Biomed Mater 2008; 1: 261-268.
16. Katti KS, Katti DR, Dash R,. Synthesis and characterization of a novel chitosan/montmorillonite/hydroxyapatite nanocomposite for bone tissue engineering. Biomed Mater 2008; 3: 034122.
17. Liang SL, Cook WD, Thouas GA, Chen QZ,. The mechanical characteristics and in vitro biocompatibility of poly(glycerol sebacate)-bioglass elastomeric composites. Biomaterials 2010; 31: 8516-8529.
18. Witte F, Feyerabend F, Maier P, Fischer J, Stormer M, Blawert C, Dietzel W, Hort N,. Biodegradable magnesium-hydroxyapatite metal matrix composites. Biomaterials 2007; 28: 2163-2174.
19. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR,. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413-3431.
20. Hartles RL,. Citrate in mineralized tissues. Adv Oral Biol 1964; 1: 225-253.
21. Dickens F,. The citric acid content of animal tissues, with reference to its occurrence in bone and tumour. Biochem J 1941; 35: 1011-1023.
22. Eastoe JE, Eastoe B,. The organic constituents of mammalian compact bone. Biochem J 1954; 57: 453-459.
23. Dixon TF, Perkins HR,. Citric acid and bone metabolism. Biochem J 1952; 52: 260-265.
24. Hu YY, Rawal A, Schmidt-Rohr K,. Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc Natl Acad Sci USA 2010; 107: 22425-22429.
25. Rhee SH, Tanaka J,. Effect of citric acid on the nucleation of hydroxyapatite in a simulated body fluid. Biomaterials 1999; 20: 2155-2160.
26. Qiu H, Yang J, Kodali P, Koh J, Ameer GA,. A citric acid-based hydroxyapatite composite for orthopedic implants. Biomaterials 2006; 27: 5845-5854.
27. Rhee SH, Tanaka J,. Hydroxyapatite formation on cellulose cloth induced by citric acid. J Mater Sci Mater Med 2000; 11: 449-452.
28. Yokoyama A, Yamamoto S, Kawasaki T, Kohgo T, Nakasu M,. Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials. Biomaterials 2002; 23: 1091-1101.
29. Jiao Y, Gyawali D, Stark JM, Akcora P, Nair P, Tran RT, Yang J,. A rheological study of biodegradable injectable PEGMC/HA composite scaffolds. Soft Matter 2012; 8: 1499-1507.
30. Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D,. Orthopaedic applications of bone graft & graft substitutes: A review. Indian J Med Res 2010; 132: 15-30.
31. Hutmacher DW, Schantz JT, Lam CX, Tan KC, Lim TC,. State of the art and future directions of scaffold-based bone engineering from a biomaterials perspective. J Tissue Eng Regen Med 2007; 1: 245-260.
32. Childs THC, Arola D,. Machining of cortical bone: Simulations of chip formation mechanics using metal machining models. Mach Sci Technol 2011; 15: 206-230.
33. Zioupos P, Gresle M, Winwood K,. Fatigue strength of human cortical bone: Age, physical, and material heterogeneity effects. J Biomed Mater Res A 2008; 86: 627-636.
34. Webb AR, Yang J, Ameer GA,. Biodegradable polyester elastomers in tissue engineering. Expert Opin Biol Ther 2004; 4: 801-812.
35. Dey J, Xu H, Shen J, Thevenot P, Gondi SR, Nguyen KT, Sumerlin BS, Tang L, Yang J,. Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials 2008; 29: 4637-4649.
36. Yang J, Webb AR, Pickerill SJ, Hageman G, Ameer GA,. Synthesis and evaluation of poly(diol citrate) biodegradable elastomers. Biomaterials 2006; 27: 1889-1898.
37. Oyane A, Kim HM, Furuya T, Kokubo T, Miyazaki T, Nakamura T,. Preparation and assessment of revised simulated body fluids. J Biomed Mater Res A 2003; 65: 188-195.
38. Ryoo HM, Lee MH, Kim YJ,. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 2006; 366: 51-57.
39. Tang W, Li Y, Osimiri L, Zhang C,. Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation. J Biol Chem 2011; 286: 32995-33002.
40. Chung EJ, Sugimoto MJ, Ameer GA,. The role of hydroxyapatite in citric acid-based nanocomposites: Surface characteristics, degradation, and osteogenicity in vitro. Acta Biomater 2011; 7: 4057-4063.
41. Dey J, Tran RT, Shen J, Tang L, Yang J,. Development and long-term in vivo evaluation of a biodegradable urethane-doped polyester elastomer. Macromol Mater Eng 2011; 296: 1149-1157.
42. Ao ZM, Jiang Q,. Size effects on miscibility and glass transition temperature of binary polymer blend films. Langmuir 2006; 22: 1241-1246.
43. Serrano CA, Zhang Y, Yang J, Schug KA,. Matrix-assisted laser desorption/ionization mass spectrometric analysis of aliphatic biodegradable photoluminescent polymers using new ionic liquid matrices. Rapid Commun Mass Spectrom 2011; 25: 1152-1158.
44. Suzuki O,. Octacalcium phosphate: Osteoconductivity and crystal chemistry. Acta Biomater 2010; 6: 3379-3387.
45. LeGeros RZ,. Properties of osteoconductive biomaterials: Calcium phosphates. Clin Orthop Relat Res 2002; 395: 81-98.
46. Imaizumi H, Sakurai M, Kashimoto O, Kikawa T, Suzuki O,. Comparative study on osteoconductivity by synthetic octacalcium phosphate and sintered hydroxyapatite in rabbit bone marrow. Calcif Tissue Int 2006; 78: 45-54.
47. Zhang C,. Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx. J Orthop Surg Res 2010; 5: 37.
48. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B,. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29.
49. Zhou X, Zhang Z, Feng JQ, Dusevich VM, Sinha K, Zhang H, Darnay BG, de Crombrugghe B,. Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice. Proc Natl Acad Sci USA 2010; 107: 12919-12924.
50. Baek WY, Lee MA, Jung JW, Kim SY, Akiyama H, de Crombrugghe B, Kim JE,. Positive regulation of adult bone formation by osteoblast-specific transcription factor osterix. J Bone Miner Res 2009; 24: 1055-1065.